FIELD: medicine.SUBSTANCE: invention can be used to predict recurrent episodes of acute respiratory viral infections (ARI) for preschool children with bronchial asthma (BA). History, clinical and laboratory risk factors are determined: absence of acute respiratory virus infection (ARI) for more than one month - x1 eosinophils level of in complete blood count (CBC) - x2 actual BA exacerbations against ARI for the last month - x3 mothers burdened obstetrical history (BOH) - x4 actual chlamydia and mycoplasma infection in history according to the enzyme-linked blood immunoassay (blood ELISA) - x5 altered level of natural killer cells (NK cells) - x6 age at first visit to the childrens pre-school institution (CPI) over three years - x7 altered level of B-lymphocytes - x8 altered level of immunoglobulin G (IgG) - x9 age of broncho-obstructive syndrome (BOS) debut - x10 altered level of tumor necrosis factor (TNF) - x11 altered level of interferon-gamma (INF-γ) - x12 altered level of phagocytic activity of monocytes - x13 prophylactic administration of antiviral drugs in the season of increased the ARI incidence - x14. At that, the risk factors x1, x3-x5, x7, x10, x14 are assigned the value of 1. Risk factors x2, x6, x8, x9, x11-x13 are assign a value, determined in laboratory tests. Then F is calculated by the formula. If F> 0, a high risk of ARI is predicted. If F <0, a minimal risk of acute respiratory viral infections for children with BA is predicted.EFFECT: method allows to predict ARI for children with BA with high probability and efficiency, to carry out preventive and rehabilitative measures in a timely manner by evaluating the most significant risk factors.1 tbl, 2 exИзобретение относится к медицине и может быть использовано для прогнозирования рецидивирующих эпизодов острой респираторной вирусной инфекции (ОРВИ) у детей дошкольного возраста с бронхиальной астмой (БА). Определяют анамнестические и клинико-лабораторные факторы риска: отсутствие острой респираторн
